NQO1 and myeloid sarcoma: Using human primary cell profiling systems in the experimental autoimmune encephalomyelitis mouse model (EAE) of MS, TFM-735, a potent Nrf2 inducer, has been shown to enhance NQO1 levels in the brain and spleen, inhibit inflammatory cytokine production, and ultimately prevent disease progression [162].